The Role of Chemotherapy for Metastatic, Relapsed and Refractory Osteosarcoma

被引:0
|
作者
Xin Xiao
Wei Wang
Zhen Wang
机构
[1] Xijing Hospital,Department of Orthopedics
[2] Forth Military Medical University,The State Key Laboratory of Cancer Biology, Department of Immunology
[3] Forth Military Medical University,undefined
来源
Pediatric Drugs | 2014年 / 16卷
关键词
Gemcitabine; Osteosarcoma; Etoposide; Ifosfamide; Topotecan;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:503 / 512
页数:9
相关论文
共 50 条
  • [31] Role of intraarterial cisplatin and intravenous adriamycin as neoadjuvant and adjuvant chemotherapy in non-metastatic osteosarcoma
    Mishra, A. N.
    Gill, J.
    Mishra, Y.
    ANNALS OF ONCOLOGY, 2017, 28
  • [32] INTENSIVE MULTIAGENT CHEMOTHERAPY IN PATIENTS WITH METASTATIC OSTEOSARCOMA AT PRESENTATION
    Abboud, Miguel R.
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 800 - 800
  • [33] Extraskeletal Osteosarcoma Outcomes and the Role of Chemotherapy
    Paludo, Jonas
    Fritchie, Karen
    Haddox, Candace L.
    Rose, Peter S.
    Arndt, Carola A. S.
    Marks, Randolph S.
    Galanis, Evanthia
    Okuno, Scott H.
    Robinson, Steven I.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (09): : 832 - 837
  • [34] Metronomic chemotherapy in pediatric relapsed or metastatic CNS tumors
    Dragomir, M.
    Badoi, M.
    Comsa, C.
    Milcu, R.
    Gruber, E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S365 - S365
  • [35] Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?
    Xu, Jie
    Guo, Wei
    Xie, Lu
    BMC CANCER, 2018, 18
  • [36] Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?
    Jie Xu
    Wei Guo
    Lu Xie
    BMC Cancer, 18
  • [37] Role of chemotherapy in relapsed ovarian cancer
    Colombo, N
    Parma, G
    Bocciolone, L
    Sideri, M
    Franchi, D
    Maggioni, A
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1999, 32 (03) : 221 - 228
  • [38] Recent Clinical Trials in Relapsed/Refractory Metastatic Colorectal Cancer
    Marshall, John L.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (03) : 3 - 7
  • [39] Relapsed/Refractory HER2+Metastatic Breast Cancer
    Brufsky, Adam M.
    Gadi, V. K.
    Hurvitz, Sara A.
    Iyengar, Neil M.
    ONCOLOGY-NEW YORK, 2021, 35 (04): : 215 - 219
  • [40] Subclonal somatic copy number alterations emerge and dominate in relapsed/refractory osteosarcoma
    Kinnaman, Michael D.
    Zaccaria, Simone
    Makohon-Moore, Alvin
    Gundem, Gunes
    Ossa, Juan E. Arango
    Bouvier, Nancy
    Dela Cruz, Filemon S.
    Hameed, Meera
    Bender, Julia Lynne Glade
    Tap, William D.
    Meyers, Paul
    Papaemmanuil, Elli
    Kung, Andrew
    Iacobuzio-Donahue, Christine A.
    CLINICAL CANCER RESEARCH, 2022, 28 (18)